Nine has won its legal challenge to orders that would have forced it to hand over a draft version of a 60 Minutes episode and restricted it from airing the program after an appeals court found a judge had no power to make the orders.
The Australian Competition and Consumer Commission is “close” to settling its case against office supply company Fujifilm over allegedly unfair contracts with small businesses, a court has heard.
A judge has revived a long-running suit against the Construction, Forestry, Maritime, Mining and Energy Union and Victorian state secretary John Setka, granting the plaintiffs leave to appeal orders dismissing the case and file an eighth iteration of their pleadings against the union over the infamous Pentridge building site.
Agricultural chemical company Nufarm has appealed a decision giving rival Advanta Seeds extra time to pay a renewal fee for its patent for a hybrid plant cell after correspondence from its lawyers was sent to employees that had left the company and the patent renewal fell through the cracks.
A judge has struck out a defence invoking the right against self-incrimination in a $2 million case brought by freight company Maersk alleging a Melbourne waste tyre company director used the shipper to dump end-of-life tyres overseas.
Mills Oakley has poached a leading employment law partner from King & Wood Mallesons for its growing workplace relations team.
A judge who ordered the first ever group costs order in a class action has found that the costs of the application should be borne by the class action.
Melbourne-based hard assets investment manager Merricks Capital has filed court proceedings to block its ex-managing director and two other former employees from working at a investment boutique run by financial commentator Peter Switzer and his son Marty.
A judge has criticised the Andrews government for withholding information about the alleged transmission of COVID-19 to a security guard working in hotel quarantine in a class action claiming lapses in the program caused Victorian businesses to suffer losses.
Regenerative medicine company Mesoblast has been hit with a second class action for allegedly misleading shareholders about it Remestemcel-L treatment for COVID-19 complications.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
